3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Leukemia
34
Precursor Cell Lymphoblastic Leukemia-Lymphoma
27
Lymphoma
27
Burkitt Lymphoma
27
Lymphoma, Non-Hodgkin
22
Lymphoma, Large B-Cell, Diffuse
22
Myelodysplastic Syndromes
20
Leukemia, Myeloid, Chronic-Phase
20
Lymphoma, Follicular
19
Leukemia, Lymphocytic, Chronic, B-Cell
18
Leukemia, Myeloid, Accelerated Phase
17
Multiple Myeloma
16
Lymphoma, Large-Cell, Immunoblastic
15
Blast Crisis
15
Myeloproliferative Disorders
14
Leukemia, Myeloid, Acute
14
Dendritic Cell Sarcoma, Interdigitating
14
Recurrence
13
Lymphoma, Mantle-Cell
13
Lymphoma, B-Cell, Marginal Zone
13
Graft vs Host Disease
13
Leukemia, Myelomonocytic, Chronic
12
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
12
Hodgkin Disease
11
Congenital Abnormalities
11
Neoplasms, Plasma Cell
10
Myelodysplastic-Myeloproliferative Diseases
10
Anemia, Refractory, with Excess of Blasts
9
Primary Myelofibrosis
8
Lymphoma, Large-Cell, Anaplastic
8
Interventions
Cyclophosphamide
17
Etoposide
10
fludarabine
9
Whole-Body Irradiation
9
Brentuximab Vedotin
9
Melphalan
8
fludarabine phosphate
7
Vincristine
7
Mycophenolic Acid
7
Gemcitabine
7
Doxorubicin
7
Prednisone
6
Granulocyte Colony-Stimulating Factor
6
Busulfan
6
Vorinostat
5
Rituximab
5
Peripheral Blood Stem Cell Transplantation
5
Lenalidomide
5
Filgrastim
5
Cytarabine
5
Bortezomib
5
romidepsin
4
pembrolizumab
4
duvelisib
4
Tacrolimus
4
Stem Cell Transplantation
4
Carmustine
4
etoposide phosphate
3
Sirolimus
3
Dexamethasone
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Lymphoma, T-Cell
×
Methylprednisolone
×
Clear all
NCT01719835
2018-03-15
CHEMO-T
Royal Marsden NHS Foundation Trust
Phase 2
Unknown
87 enrolled